Emmes Corp. Appoints Dr. Nilay Shay as VP of Strategic Partnerships and Medical Officer

Dr. Nilay Shah is vice president of strategic partnerships and medical officer. He started his career practicing medicine overseas and then worked as a clinical researcher at the University of Pennsylvania. Dr. Shah started at Emmes in 2005 as a safety/medical monitor before assuming leadership roles in ophthalmology, autoimmune and inflammation projects. He has more than 15 years of experience in leading various commercial studies, many of which have received regulatory approval. More recently, he led a privately funded device study using Artificial Intelligence (AI), which resulted in its being the first and only FDA-cleared diagnostic AI system to detect diabetic retinopathy in the ophthalmic space. Dr. Shah also has been actively involved in business development.

According to Dr. Shah, “Our long and productive partnerships with our clients – and the scientific value we bring – are part of our legacy. I’m excited to expand this into building new relationships with business partners, both domestically and internationally, that offer skill sets and values that complement ours.”

Dr. Shah has written numerous ophthalmic-related papers in a wide range of scientific journals, and he is a grant reviewer at The Maryland Technology Development Corporation, known as TEDCO, for the Maryland Innovation Initiative. He attended Rutgers University before obtaining his MBBS degree in medicine and surgery from the Somaiya Medical College and Research Center at the University of Mumbai in India (MD equivalent in the U.S.)

“Dr. Shah is a passionate advocate for finding truth in research, reflecting our vision of being the trusted partner to researchers seeking to improve human health,” said Dr. Lindblad. “He is an innovative thinker and problem solver, and he uses those skills to understand client needs and deliver solutions.”

About Emmes
We collaborate with our clients to produce valued, trusted scientific research. Our team members at Emmes are passionate about making a difference in the quality of human health, and we have supported more than a thousand studies across a diverse range of diseases since our formation in 1977. Our research is contributing to a healthier world. For more information, visit the Emmes website at www.emmes.com.

Download Press Release 

The following two tabs change content below.
Chris Frew
Over the past 8 years, Chris has grown BioBuzz into a respected brand that is recognized for its community building, networking events and news stories about the local biotech industry. In addition, he runs a Recruiting and Marketing Agency that helps companies attract top talent through a blended model that combines employer branding and marketing services together with a high powered recruiting solution.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.